Meteora Capital’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Meteora Capital’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50,000	Closed	-$14.9K	–	495
2022 Q4	$14.9K	Buy	+50,000	New	+$10.1K	﹤0.01%	228

Meteora Capital's EBACW Position: Q1 2023 in Review

Meteora Capital sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 50,000 shares — an estimated $14.9K sold.

Meteora Capital first reported a position in EBACW in Q4 2022 and held it in 1 quarter. The position peaked at $14.9K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Meteora Capital reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Meteora Capital sold 50,000 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $14.9K.
Meteora Capital first reported a position in European Biotech Acquisition Corp. Warrant in Q4 2022 and held it in 1 quarter.
Meteora Capital's European Biotech Acquisition Corp. Warrant position peaked at $14.9K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Meteora Capital's 13F filing for Q1 2023, filed 15 May 2023.